SARS-CoV-2 HLA-A2 Restricted Epitope Peptide and Its Application
CN117903264BActive Publication Date: 2026-04-03THE NAVAL MEDICAL UNIV OF PLA
-1 Cites -1 Cited by
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-26
- Publication Date
- 2026-04-03
Abstract
This document provides a SARS-CoV-2 HLA-A2 restricted epitope peptide and its applications. Specifically, this document provides an isolated polypeptide with the amino acid sequence IFLWLLWPV (SEQ ID NO:2), which is a SARS-CoV-2 HLA-A2 restricted epitope peptide. This document also provides complexes comprising the said polypeptide, articles thereof, and their applications. The active substances and products related to this application can be used for the detection, diagnosis, prevention, and / or treatment of SARS-CoV-2 related diseases.
Need to check novelty before this filing date? Find Prior Art